Aligos Therapeutics (ALGS) Short-term Investments (2021 - 2025)
Historic Short-term Investments for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $57.2 million.
- Aligos Therapeutics' Short-term Investments rose 4435.1% to $57.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.2 million, marking a year-over-year increase of 4435.1%. This contributed to the annual value of $19.9 million for FY2024, which is 1984200.0% up from last year.
- As of Q3 2025, Aligos Therapeutics' Short-term Investments stood at $57.2 million, which was up 4435.1% from $104.3 million recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' Short-term Investments ranged from a high of $104.3 million in Q2 2025 and a low of $42000.0 during Q2 2023
- In the last 5 years, Aligos Therapeutics' Short-term Investments had a median value of $39.6 million in 2024 and averaged $38.8 million.
- In the last 5 years, Aligos Therapeutics' Short-term Investments plummeted by 9995.24% in 2023 and then soared by 11765714.29% in 2024.
- Aligos Therapeutics' Short-term Investments (Quarter) stood at $3.9 million in 2021, then skyrocketed by 1035.27% to $44.5 million in 2022, then tumbled by 99.78% to $100000.0 in 2023, then surged by 19842.0% to $19.9 million in 2024, then soared by 186.58% to $57.2 million in 2025.
- Its Short-term Investments was $57.2 million in Q3 2025, compared to $104.3 million in Q2 2025 and $64.1 million in Q1 2025.